Shandong Weigao Group Medical Polymer Co (UK2) AI Stock Analysis

1 Followers

Shandong Weigao Group Medical Polymer Co

(Frankfurt:UK2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Recurring consumables demandThe company serves routine clinical workflows with disposable products that are consumed and replenished regularly. This recurring volume-based model can support durable demand across hospital and clinic channels, while broader patient utilization and procurement-list penetration provide avenues for sustained sales.

Negative Factors

Sharp revenue declineThe sharp 2025 revenue contraction signals a material weakening in demand, sales execution, product mix, or procurement conditions. Because revenue had already been broadly flat beforehand, the decline raises concern that near-term recovery may require renewed volume growth rather than merely cycling a temporary slowdown.

Shandong Weigao Group Medical Polymer Co (UK2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.87B
Dividend Yield: 5.12%
Average Volume (3M): 4
Price to Earnings (P/E): 9.4
Beta (1Y): 0.24
Revenue Growth: -0.09%
EPS Growth: -32.00%
Country: Germany
Employees: 13,310
Sector: Healthcare
Sector Strength: 51
Industry: Medical - Instruments & Supplies

Shandong Weigao Group Medical Polymer Co Business Overview & Revenue Model

Company Description

Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The...

Shandong Weigao Group Medical Polymer Co Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

DE:UK2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
HK:3600	80Outperform	HKD 6.90B	10.14	20.11%	3.92%	12.50%	44.44%
HK:6929	78Outperform	HKD 3.02B	8.73	10.50%	5.44%	16.25%	7.80%
HK:6699	66Neutral	HKD 13.52B	41.04	8.95%	1.21%	―	―
HK:1501	64Neutral	HKD 6.24B	21.49	9.64%	0.87%	34.94%	12.99%
HK:1358	61Neutral	HKD 1.25B	25.88	1.10%	3.56%	-1.64%	-68.67%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

* Healthcare Sector Average

Performance Comparison

DE:UK2 and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:UK2	Shandong Weigao Group Medical Polymer Co Class H	0.34	-0.20	-36.88%
HK:1358	PW Medtech Group Ltd.	0.87	-0.48	-35.41%
HK:3600	Modern Dental Group Limited	7.40	2.30	45.10%
HK:1501	Shanghai Kindly Medical Instruments Co., Ltd. Class H	29.80	-0.92	-2.98%
HK:6699	Angelalign Technology Inc.	80.05	19.56	32.33%
HK:6929	OrbusNeich Medical Group Holdings Limited	3.67	-0.52	-12.39%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Shandong Weigao Group Medical Polymer Co AI Stock Analysis